Faces of Digital Health

OpenEvidence didn't leave Europe because of regulation alone — its ad-and-data business model never fit the European market. When OpenEvidence, the $12B clinical AI search platform used daily by over 40% of US physicians, withdrew from the EU and UK in April 2026 citing the EU AI Act, European clinicians lost a tool many had quietly adopted. In this episode, Philippe Habets — physician-scientist a...

AI models are "eager to please" — and in healthcare, that's a liability. So what should LLMs never be allowed to do in clinical software? Three years after GPT-3 reached the public, frontier models have largely converged in capability. In this episode, Robert Tovornik, Innovation Lead at Better — the healthcare IT company building on openEHR — explains why the real differentiator in healthcare AI ...

AI couldn't cure his mother's stage 4 cancer. It caught three near-fatal errors, found a same-day appointment, and helped her leave on her own terms. When Pratik Desai's mother was diagnosed with stage four duodenal adenocarcinoma — a rare cancer with roughly 3,000 US cases a year — she was nearly discharged without an oncology appointment. Over the next 76 days, Desai used AI at her bedside, from...

AI ethicist Jess Morley: these chatbots are giving medical advice — so regulate them as medical devices. Part of The Agentic Patient, a Faces of Digital Health series on how patients actually use AI — which tools, which prompts, which safeguards. In this episode, host Tjaša Zajc sits down with Dr Jess Morley, Associate Research Scientist at the Yale Digital Ethics Center and a former AI subject-ma...

98% of patients welcome AI in their care — and still want a human in charge. That tension ran through the OECD and Spanish Ministry of Health conference on scaling AI in health (Madrid, late May 2026), and it frames this episode of Faces of Digital Health. Out of 38 OECD countries, only seven have a formal AI strategy and just over a tenth run workforce upskilling programmes — the ambition is outr...

Doctors are using ChatGPT in clinic right now — and some of them don't care about privacy. Three operators on what that means for healthcare AI. Recorded live at health.tech in Basel, this panel from Faces of Digital Health unpacks the convergence reshaping clinical software: ambient AI scribes, agentic AI in healthcare, on-device LLMs, and the regulatory drag (MDR, EU AI Act, EHDS) that is wideni...

Most conversations about agentic AI in healthcare get stuck on capability. This one is about the gap between capability and deployment — and what closes it. Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, argues that healthcare's bottleneck isn't vision; it's courage. The processes are documented poorly or not at all, AI fluency programs reach a fraction of emp...

The Agentic Patient is here — and most healthcare systems don't have a plan for it. In this special reverse-role episode of Faces of Digital Health, Eric Sutherland interviews host Tjaša Zajc about what a year of using AI through her own chronic illness has actually taught her about patients, doctors, and the future of healthcare AI. 200 million people will ask ChatGPT a health question this week....

When Demetri Giannikopoulos was diagnosed with multiple sclerosis, his community neurologist handed him a sheet with fifty medication options and told him to pick one. That was a long time ago. Today he's the Chief Innovation Officer at RadAI, overseeing how artificial intelligence gets deployed in radiology across US health systems — and he's spent two decades learning how to navigate a healthcar...